These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 33752263)

  • 1. Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external experts.
    Ring J; Worm M; Wollenberg A; Thyssen JP; Jakob T; Klimek L; Bangert C; Barbarot S; Bieber T; de Bruin-Weller MS; Chernyshov PV; Christen-Zaech S; Cork M; Darsow U; Flohr C; Fölster-Holst R; Gelmetti C; Gieler U; Gutermuth J; Heratizadeh A; Hijnen DJ; von Kobyletzki LB; Kunz B; Paul C; De Raeve L; Seneschal J; Simon D; Spuls PI; Stalder JF; Svensson A; Szalai Z; Taieb A; Torrelo A; Trzeciak M; Vestergaard C; Werfel T; Weidinger S; Deleuran M
    J Eur Acad Dermatol Venereol; 2021 Jun; 35(6):e362-e365. PubMed ID: 33752263
    [No Abstract]   [Full Text] [Related]  

  • 2. ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines - An EAACI-ARIA Position Paper.
    Klimek L; Jutel M; Akdis CA; Bousquet J; Akdis M; Torres MJ; Agache I; Canonica GW; Del Giacco S; O'Mahony L; Shamji MH; Schwarze J; Untersmayr E; Ring J; Bedbrook A; Worm M; Zuberbier T; Knol E; Hoffmann-Sommergruber K; Chivato T
    Allergy; 2021 Jun; 76(6):1624-1628. PubMed ID: 33378789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Not Available].
    Klimek L; Chaker AM; Cuevas M
    Laryngorhinootologie; 2021 May; 100(5):344-354. PubMed ID: 33684947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [MANAGEMENT, DIAGNOSIS, AND TREATMENT OF SEVERE ALLERGIC REACTIONS INCLUDING ANAPHYLAXIS TO COVID-19 VACCINE].
    Asano K; Fujisawa T; Nakamura Y; Nagata M; Hide M; Fujieda S
    Arerugi; 2021; 70(3):215-223. PubMed ID: 34011777
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of patients at risk of anaphylaxis after COVID 19 vaccination.
    Gangemi S; Allegra A; Di Gioacchino M
    J Biol Regul Homeost Agents; 2021; 35(3):843-846. PubMed ID: 34231348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergic Reactions After COVID-19 Vaccination-Putting Risk Into Perspective.
    Phillips EJ
    JAMA Netw Open; 2021 Aug; 4(8):e2122326. PubMed ID: 34463751
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine.
    Yacoub MR; Cucca V; Asperti C; Ramirez GA; Della-Torre E; Moro M; Zandalasini C; Di Napoli D; Ambrosio A; Signorelli C; Colombo S; Beretta L; Ciceri F; Zangrillo A; Dagna L
    Vaccine; 2021 Oct; 39(44):6464-6469. PubMed ID: 34598820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines for COVID-19 in patients with atopic dermatitis: three things every dermatologist should know.
    Diotallevi F; Simonetti O; Radi G; Molinelli E; Rizzetto G; Cirioni O; D'Errico MM; Offidani A
    Acta Dermatovenerol Alp Pannonica Adriat; 2021 Jun; 30(2):67-69. PubMed ID: 34169702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [COVID-19 vaccines: vaccine targets, immunogenicity and allergic reactions].
    Fallet B; Miauton A; Comte D; Ribi C; Muller YD
    Rev Med Suisse; 2021 Apr; 17(733):690-696. PubMed ID: 33830701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights from American College of Allergy, Asthma, and Immunology COVID-19 Vaccine Task Force: Allergic Reactions to mRNA SARS-CoV-2 Vaccines.
    Murphy KR; Patel NC; Ein D; Hudelson M; Kodoth S; Marshall GD; Parikh P; Blaiss MS
    Ann Allergy Asthma Immunol; 2021 Apr; 126(4):319-320. PubMed ID: 33493641
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety of New mRNA Vaccines Against COVID-19 in Severely Allergic Patients.
    Rojas-Pérez-Ezquerra P; Crespo Quirós J; Tornero Molina P; Baeza Ochoa de Ocáriz ML; Zubeldia Ortuño JM
    J Investig Allergol Clin Immunol; 2021 Apr; 31(2):180-181. PubMed ID: 33648905
    [No Abstract]   [Full Text] [Related]  

  • 12. Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines.
    Moghimi SM
    Mol Ther; 2021 Mar; 29(3):898-900. PubMed ID: 33571463
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19 vaccination: Recommendations for management of patients with allergy or immune-based diseases.
    Peter J
    S Afr Med J; 2021 Feb; 111(4):291-294. PubMed ID: 33944757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of anaphylaxis due to COVID-19 vaccines in the elderly.
    Bousquet J; Agache I; Blain H; Jutel M; Ventura MT; Worm M; Del Giacco S; Benetos A; Bilo BM; Czarlewski W; Abdul Latiff AH; Al-Ahmad M; Angier E; Annesi-Maesano I; Atanaskovic-Markovic M; Bachert C; Barbaud A; Bedbrook A; Bennoor KS; Berghea EC; Bindslev-Jensen C; Bonini S; Bosnic-Anticevich S; Brockow K; Brussino L; Camargos P; Canonica GW; Cardona V; Carreiro-Martins P; Carriazo A; Casale T; Caubet JC; Cecchi L; Cherubini A; Christoff G; Chu DK; Cruz AA; Dokic D; El-Gamal Y; Ebisawa M; Eberlein B; Farrell J; Fernandez-Rivas M; Fokkens WJ; Fonseca JA; Gao Y; Gavazzi G; Gawlik R; Gelincik A; Gemicioğlu B; Gotua M; Guérin O; Haahtela T; Hoffmann-Sommergruber K; Hoffmann HJ; Hofmann M; Hrubisko M; Illario M; Irani C; Ispayeva Z; Ivancevich JC; Julge K; Kaidashev I; Khaitov M; Knol E; Kraxner H; Kuna P; Kvedariene V; Lauerma A; Le LTT; Le Moing V; Levin M; Louis R; Lourenco O; Mahler V; Martin FC; Matucci A; Milenkovic B; Miot S; Montella E; Morais-Almeida M; Mortz CG; Mullol J; Namazova-Baranova L; Neffen H; Nekam K; Niedoszytko M; Odemyr M; O'Hehir RE; Okamoto Y; Ollert M; Palomares O; Papadopoulos NG; Panzner P; Passalacqua G; Patella V; Petrovic M; Pfaar O; Pham-Thi N; Plavec D; Popov TA; Recto MT; Regateiro FS; Reynes J; Roller-Winsberger RE; Rolland Y; Romano A; Rondon C; Rottem M; Rouadi PW; Salles N; Samolinski B; Santos AF; S Sarquis F; Sastre J; M G A Schols J; Scichilone N; Sediva A; Shamji MH; Sheikh A; Skypala I; Smolinska S; Sokolowska M; Sousa-Pinto B; Sova M; Stelmach R; Sturm G; Suppli Ulrik C; Todo-Bom AM; Toppila-Salmi S; Tsiligianni I; Torres M; Untersmayr E; Urrutia Pereira M; Valiulis A; Vitte J; Vultaggio A; Wallace D; Walusiak-Skorupa J; Wang DY; Waserman S; Yorgancioglu A; Yusuf OM; Zernotti M; Zidarn M; Chivato T; Akdis CA; Zuberbier T; Klimek L
    Allergy; 2021 Oct; 76(10):2952-2964. PubMed ID: 33811358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 Vaccination in Patients with Reported Allergic Reactions: Updated Evidence and Suggested Approach.
    Banerji A; Wolfson AR; Wickner PG; Cogan AS; McMahon AE; Saff R; Robinson LB; Phillips E; Blumenthal KG
    J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2135-2138. PubMed ID: 33866033
    [No Abstract]   [Full Text] [Related]  

  • 16. Allergic reactions to the first COVID-19 vaccine: A potential role of polyethylene glycol?
    Cabanillas B; Akdis CA; Novak N
    Allergy; 2021 Jun; 76(6):1617-1618. PubMed ID: 33320974
    [No Abstract]   [Full Text] [Related]  

  • 17. [COVID-19 vaccines increase the risk of anaphylaxis].
    Alnæs M; Storaas T; Sørensen M; Stylianou E; Tøndell A
    Tidsskr Nor Laegeforen; 2021 Mar; 141(4):. PubMed ID: 33685103
    [No Abstract]   [Full Text] [Related]  

  • 18. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Allergic reactions to COVID-19 vaccines].
    Geersing TH; Tempels-Pavlica Ž; Borgsteede SD
    Ned Tijdschr Geneeskd; 2021 Feb; 165():. PubMed ID: 33651507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ascertainment Bias in Anaphylaxis Safety Data of COVID-19 Vaccines.
    Hourihane JO; Byrne AM; Blümchen K; Turner PJ; Greenhawt M
    J Allergy Clin Immunol Pract; 2021 Jul; 9(7):2562-2566. PubMed ID: 34246432
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.